A series of bis(N-methylcarbamate) and bis[N-(2-propyl)carbamate] derivatives of 5-substituted 6,7-bis(hydroxy-methyl)pyrrolo[1,2-c]thiazoles was prepared. The compounds were tested for activity in vivo against P388 lymphocytic leukemia, and the chemical reactivities of the compounds were compared by using the model nucleophile 4-(4-nitrobenzyl)pyridine (NBP). The 5-(3,4-dichlorophenyl)-substituted
制备了一系列5-取代的6,7-双(羟基-甲基)
吡咯并[1,2-c]
噻唑的双(N-
甲基氨基甲酸酯)和双[N-(2-丙基)
氨基甲酸酯]衍
生物。测试了这些化合物在体内对P388淋巴细胞白血病的活性,并通过使用模型亲核试剂4-(4-硝基苄基)
吡啶(NBP)比较了化合物的
化学反应性。5-(3,4-二
氯苯基)取代的双
氨基甲酸酯6b,8b和12b对NBP无活性且无反应性。5-甲基取代的双
氨基甲酸酯6a,7a,8a,9a,12a和13a均具有抗鼠P388淋巴细胞白血病的活性。活性化合物的
化学反应性取决于
硫的氧化态。对NBP的反应性的阶数S大于SO,远大于SO2。砜12a和13a是该系列中活性最高的化合物,